Here, FXR inhibition attenuated atherosclerosis through reducing expression of CD36, the main transporter in macrophages for the uptake of oxidized LDL, consequently reducing cholesterol accumulation in macrophages and foam cell formation [86]. This evidence concerns the gene NR1H4 and atherosclerosis.